THEOPHYLLINE-SR Drug Patent Profile
✉ Email this page to a colleague
When do Theophylline-sr patents expire, and when can generic versions of Theophylline-sr launch?
Theophylline-sr is a drug marketed by Scherer Rp and is included in one NDA.
The generic ingredient in THEOPHYLLINE-SR is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theophylline-sr
A generic version of THEOPHYLLINE-SR was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THEOPHYLLINE-SR?
- What are the global sales for THEOPHYLLINE-SR?
- What is Average Wholesale Price for THEOPHYLLINE-SR?
Summary for THEOPHYLLINE-SR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Clinical Trials: | 111 |
| Patent Applications: | 5,819 |
| DailyMed Link: | THEOPHYLLINE-SR at DailyMed |
Recent Clinical Trials for THEOPHYLLINE-SR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Tanta University | N/A |
| LG Chem | Phase 1 |
| Medical College of Wisconsin | Phase 1/Phase 2 |
US Patents and Regulatory Information for THEOPHYLLINE-SR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scherer Rp | THEOPHYLLINE-SR | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 088255-001 | Jun 12, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
